FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/20/2026
Back to search
Official data from USPTO
BIOMEBANK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOMEBANK
ST13
US500000079378921Class
5, 42, 44
Filing
79378921
Registration
8097613
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/20/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
08/23/2023
Registration date
01/13/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2026
Last transaction
08/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
BURRUS, JESSICA E
Current location
Historical data usage
Holders and representatives
Holders
COST-BRY PTY LTD
Representatives
Jocelyn C. Smith UB Greensfelder LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological agentsbacterial fungicidesfungicidesweedkillersherbicidesinsecticidesparasiticidespesticides; biological control agents being pesticides; biological preparations for medical purposesthe treatment of cancer; biological preparations for pharmaceutical purposesthe treatment of cancer; biological preparations for use in cell cultures in biotechnology for medical purposes; biological preparations for use in cell cultures for medical purposes; biological products being reagents for medical use; biological substances being reagents for medical use; biological tissue cultures for medical purposes; biological reagants for use in biological processing for medical purposes; bacteriological culture mediums for medical purposes or veterinary purposes; bacteriological cultures for medical and veterinary use; bacteriological preparations for medical and veterinary use; diagnostic test reagants for medical use in detecting allergenic substances
Class 42
Biological research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; bacteriological research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; biotechnology research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; biotechnology testing of materials in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; advisory services relating to scientific research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; technology advisory services related to biotechnological engineering research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; biochemistry research services in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific research in the field of biotechnology animal genetics research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; medical research services in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific research for medical purposes in the field of cancerous diseases for the developmenttestingtreatment of cultured microbial therapies; scientific researchpreparation of reports in the field of in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; Technical researchin the field of in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific researchconducting statistical scientific studies in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; providing information in the field of scientific and technological research and design services via a web site in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; provision of information relating to scientific research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; provision of medical research services in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; rental of scientific research facilities in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; research and development of new products in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific research in the field of bacteriology for the developmenttestingtreatment of cultured microbial therapies; scientific research and development of new products in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific research in the field of biology for the developmenttestingtreatment of cultured microbial therapies; scientific research in the field of genetics for the developmenttestingtreatment of cultured microbial therapies; technological research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; providing scientific information in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies; scientific research in the field of microbiologybacteriology and microbiome therapy for the developmenttestingtreatment of cultured microbial therapies.
Class 44
Medical advisory servicesadvisory services relating to medical services for the testing and treatment of cultured microbial therapies; alternative medical services for the testing and treatment of cultured microbial therapies; charitable servicesproviding medical services to underserved communities for the testing and treatment of cultured microbial therapies; medical services in the field of gastroenterology for the testing and treatment of cultured microbial therapies; medical diagnostic services in the nature of testing and analysis services for the testing and treatment of cultured microbial therapies; medical advisory servicesadvisory services relating to medical problems for the testing and treatment of cultured microbial therapies.
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/05/2026
FIMP
FINAL DISPOSITION PROCESSED
08/05/2026
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
08/05/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/01/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/13/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/02/2026
CHPN
POST PUBLICATION AMENDMENT – NOT ENTERED
01/14/2026
APET
ASSIGNED TO PETITION STAFF
01/13/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/13/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/13/2026
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
12/18/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
11/10/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/28/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
07/07/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/10/2025
PUBO
PUBLISHED FOR OPPOSITION
06/10/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/04/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/06/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/01/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/06/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/30/2024
RFNT
REFUSAL PROCESSED BY IB
07/28/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/06/2024
RFRR
REFUSAL PROCESSED BY MPU
07/06/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/05/2024
CNRT
NON-FINAL ACTION WRITTEN
05/17/2024
DOCK
ASSIGNED TO EXAMINER
04/24/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/19/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/14/2023
Continuous trademark protection
Get notified about every new filing that threatens BIOMEBANK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.